Cell Microsystems News Today

Cell Microsystems, a leading provider of advanced tools for cell biology, is excited to announce a strategic partnership with OMNI Life Science (OLS), a renowned German cell biology company.

The North Carolina Biotechnology Center awarded 21 grants and loans totaling about $1.79 million to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year. Here are the details.

Cell Microsystems recently announced its acquisition of Oakland, California-based Fluxion Biosciences, a developer of automated patch clamp technology and cell-based assay tools. Here's what's happening.

Discover how to improve the efficiency and success of iPSC cloning, while decreasing time, expense, and effort.

Cell Microsystems is a biotechnology company that has created the CellRaft® technology. Concurrent to the acquisition the company announced Series B financing led by Telegraph Hill Partners.

Watch this webinar to explore the use of hPSC-derived cell models to study human health, development, and disease

In this article, Cell Microsystems demonstrates how to accelerate the use of iPSCs in drug development and personalized medicine.

Discover what solutions are available to automate cloning for CRISPR workflows, allowing for the simultaneous screening of thousands of single cells.

In this article, Cell Microsystems details the solutions available to researchers to accelerate the development of in vitro models of chemoresistance.

/PRNewswire/ -- The "Genomics Global Market Report 2023" report has been added to ResearchAndMarkets.coms offering. This report provides strategists,...